Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 1/20 | 0.46 |
| ▸ | CCR1 | P32246 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | CCR5 | P51681 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | GLO1 | Q04760 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | SLC40A1 | Q9NP59 | 2/20 | 0.35 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.35 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.35 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5696378 | 0.79 | CCR1 (0.48) | METAP2CCR1RAB9ACCR5GLO1 | |
| SCHEMBL2115749 | 0.78 | CCR1 (0.64) | METAP2CCR1RAB9ACCR5PARP1 | |
| SCHEMBL9673747 | 0.73 | ALDH1A1 (0.44) | PARP1MEN1KMT2ACYP1A2TSHR | |
| SCHEMBL27594921 | 0.70 | METAP2 (0.53) | METAP2CCR1RAB9ACCR5PARP1 | |
| SCHEMBL5696379 | 0.70 | SLC6A3 (0.41) | RAB9ACYP1A2TDP1SMN1; SMN2TSHR | |
| SCHEMBL28006187 | 0.70 | — | — | |
| SCHEMBL9268395 | 0.70 | HPRT1 (0.48) | RAB9AMEN1KMT2APAX8CYP1A2 | |
| SCHEMBL6242909 | 0.69 | SLC6A3 (0.40) | RAB9ACYP1A2TDP1SMN1; SMN2TSHR | |
| SCHEMBL2116625 | 0.69 | METAP2 (0.52) | METAP2CCR1RAB9ACCR5PARP1 | |
| SCHEMBL113609 | 0.68 | TRPA1 (0.35) | RAB9APARP1CYP1A2SMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6995267-B2 | Method for producing cyclopentadiene compounds | BASELL POLYOLEFINE GMBH (DE) | 2006-02-07 | — | — | US | disclosed |
| US-20040097749-A1 | Method for producing cyclopentadiene compounds | EQUISTAR CHEMICALS, LP | 2004-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040097749-A1 | Method for producing cyclopentadiene compounds | DHPS, FDPS, CYCS | METAP2 1558/4885CCR1 1925/4885RAB9A 3374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.